Physician profile
Vafa C Mansouri
NPI 1659342384
$1,811.37
in general payments reported to CMS, 2019-2025
21 companies · $1,027 in 2025
The $1,027 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.36 · 2020: $13.23 · 2021: $3.13 · 2022: $173 · 2023: $269 · 2024: $274 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,570.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $425.60 | 2022-2025 | Watchman Access System, Cds - Mct/Cem Monitoring, Bodyguardian |
| Astrazeneca Pharmaceuticals LP | $244.02 | 2020-2025 | Farxiga |
| Amgen INC. | $142.79 | 2025 | Repatha, Repatha |
| Novo Nordisk INC | $132.65 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Alnylam Pharmaceuticals INC. | $117.99 | 2025 | Onpattro |
| Pfizer INC. | $98.07 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.10 | 2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $85.98 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $73.53 | 2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.84 | 2019-2025 | Lifevest |
| Glaxosmithkline, LLC. | $63.99 | 2025 | Arexvy, Shingrix |
| Inspire Medical Systems, INC. | $42.23 | 2023 | Inspire |
| Bridgebio Pharma, INC. | $41.51 | 2025 | Attruby |
| Geistlich Pharma, North America, INC. | $36.78 | 2024 | Geistlich Bio-Gide |
| Abbott Laboratories | $32.60 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $26.19 | 2025 | Ecc Solutions |
| Cardiva Medical, INC. | $19.76 | 2025 | Optowire |
| Sanofi-Aventis U.S. LLC | $19.46 | 2019 | |
| Medtronic, INC. | $18.04 | 2024 | Symplicity G3 |
| Terumo Medical Corporation | $15.63 | 2023 | Angio-Seal, Glidewire |
| E.R. Squibb & Sons, L.L.C. | $13.61 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vafa Mansouri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.